natgillin/translations-raw huggingface dataset:
Hvis det er tilfældet, skal indehaveren af tilladelsen sammenholde oplysningerne om nye udtrykte proteiners ekspressionsniveauer.
SYN-BTØ11-1 maize expresses the Cry1Ab protein which confers protection against certain lepidopteran pests and a PAT protein which confers tolerance to glufosinate-ammonium herbicides.
Plan for overvågning af de miljømæssige konsekvenser
DAS-59122-7 maize expresses the Cry34Ab1 and Cry35Ab1 proteins which confer protection against certain coleopteran pests and a PAT protein which confers tolerance to glufosinate-ammonium herbicides.
Plan for overvågning af de miljømæssige konsekvenser, jf. bilag VII til direktiv 2001/18/EF.
SYN-IR6Ø4-5 maize expresses the modified Cry3A protein which provides protection against certain coleopteran pests and PMI protein which was used as a selectable marker.
[Link: plan offentliggjort i fællesskabsregistret over genetisk modificerede fødevarer og foderstoffer]
DAS-Ø15Ø7-1 maize expresses the Cry1F protein which confers protection against certain lepidopteran pests and the PAT protein, used as a selectable marker, which confers tolerance to the glufosinate-ammonium herbicide
Krav om overvågning af fødevarens anvendelse til konsum efter markedsføring
MON-ØØØ21-9 maize expresses the mEPSPS protein which confers tolerance to glyphosate herbicides.
Ingen.
Labelling:
Bemærk: Det kan blive nødvendigt senere at ændre link til relevante dokumenter.
For the purposes of the labelling requirements laid down in Article 13(1) and Article 25(2) of Regulation (EC) No 1829/2003, and in Article 4(6) of Regulation (EC) No 1830/2003, the ‘name of the organism’ shall be ‘maize’;
Sådanne ændringer offentliggøres ved ajourføring af fællesskabsregistret over genetisk modificerede fødevarer og foderstoffer.
The words ‘not for cultivation’ shall appear on the label of and in the accompanying documents of the products containing or consisting the maizes specified in (e) with the exception of products referred to in point (a) of Article 2.
På vegne af Syngenta Crop Protection AG, Schwarzwaldallee 215, CH-4058 Basel, Schweiz
Method for detection:
EFSA's GMO-panel (EFSA's Panel for Genetisk Modificerede Organismer), 2016: Scientific Opinion on an application by Syngenta (EFSA-GMO-DE-2011-99) for the placing on the market of maize Bt11 × 59122 × MIR604 × 1507 × GA21 and twenty subcombinations, which have not been authorised previously independently of their origin, for food and feed uses, import and processing under Regulation (EC) No 1829/2003 (EFSA Journal 2016;14(8):4567 [31 s.].
Event specific real-time quantitative PCR based methods for SYN-BTØ11-1, DAS-59122-7, SYN-IR6Ø4-5, DAS-Ø15Ø7-1 and MON-ØØØ21-9 maizes; the detection methods are validated on the single-trait events and verified on genomic DNA extracted from seeds of SYN-BTØ11-1 × DAS-59122-7 × SYN-IR6Ø4-5 × DAS-Ø15Ø7-1 × MON-ØØØ21-9 maize;
DOI:10.2903/j.efsa.2016.4567).
Validated by the EU Reference Laboratory established under Regulation (EC) No 1829/2003, published at http://gmo-crl.jrc.ec.europa.eu/statusofdossiers.aspx;
SYN-BTØ11-1 × DAS-59122-7 × SYN-IR6Ø4-5 × DAS-Ø15Ø7-1 × MON-ØØØ21-9
Reference Material: ERM®-BF412 (for SYN-BTØ11-1), ERM®-BF424 (for DAS-59122-7), ERM®-BF423 (for SYN-IR6Ø4-5) and ERM®-BF418 (for DAS-Ø15Ø7) accessible via the Joint Research Centre (JRC) of the European Commission, Institute for Reference Materials and Measurements (IRMM) at https://crm.jrc.ec.europa.eu and AOCS 0407-A and AOCS 0407-B (for MON-ØØØ21-9) accessible via the American Oil Chemists Society at http://www.aocs.org/LabServices/content.cfm?ItemNumber=19248.
SYN-BTØ11-1 × SYN-IR6Ø4-5 × DAS-Ø15Ø7-1 × MON-ØØØ21-9
Unique identifier:
SYN-BTØ11-1 × DAS-59122-7 × DAS-Ø15Ø7-1 × MON-ØØØ21-9
Information required under Annex II to the Cartagena Protocol on Biosafety to the Convention on Biological Diversity:
SYN-BTØ11-1 × DAS-59122-7 × SYN-IR6Ø4-5 × MON-ØØØ21-9
[Biosafety Clearing-House, Record ID number: published in the Community register of genetically modified food and feed when notified].
SYN-BTØ11-1 × DAS-59122-7 × SYN-IR6Ø4-5 × DAS-Ø15Ø7-1
Conditions or restrictions on the placing on the market, use or handling of the products:
DAS-59122-7 × SYN-IR6Ø4-5 × DAS-Ø15Ø7-1 × MON-ØØØ21-9
Specific conditions in accordance with Article 6(5)(e) and Article 18(5)(e) of Regulation (EC) No 1829/2003:
SYN-BTØ11-1 × DAS-59122-7 × SYN-IR6Ø4-5
The authorisation holder shall inform the Commission if any of the sub-combinations were to be created via targeted breeding approaches and commercialised.
SYN-BTØ11-1 × DAS-59122-7 × DAS-Ø15Ø7-1
If it is the case, the authorisation holder shall collate information on the expression levels of the newly expressed proteins.
SYN-BTØ11-1 × DAS-59122-7 × MON-ØØØ21-9
Monitoring plan for environmental effects:
SYN-BTØ11-1 × SYN-IR6Ø4-5 × DAS-Ø15Ø7-1
Monitoring plan for environmental effects conforming with Annex VII to Directive 2001/18/EC.
SYN-BTØ11-1 × DAS-Ø15Ø7-1 × MON-ØØØ21-9
[Link: plan published in the Community register of genetically modified food and feed]
DAS-59122-7 × SYN-IR6Ø4-5 × DAS-Ø15Ø7-1
Post market monitoring requirements for the use of the food for human consumption
DAS-59122-7 × SYN-IR6Ø4-5 × MON-ØØØ21-9
Not required.
DAS-59122-7 × DAS-Ø15Ø7-1 × MON-ØØØ21-9
Note: links to relevant documents may need to be modified over the time.
SYN-IR6Ø4-5 × DAS-Ø15Ø7-1 × MON-ØØØ21-9
Those modifications will be made available to the public via the updating of the Community register of genetically modified food and feed.
SYN-BTØ11-1 × DAS-59122-7
On behalf of Syngenta Crop Protection AG, Schwarzwaldallee 215, CH-4058 Basel, Switzerland .
SYN-BTØ11-1 × DAS-Ø15Ø7-1
EFSA GMO Panel (EFSA Panel on Genetically Modified Organisms), 2016.
DAS-59122-7 × SYN-IR6Ø4-5
Scientific Opinion on an application by Syngenta (EFSA-GMO-DE-2011-99) for the placing on the market of maize Bt11 × 59122 × MIR604 × 1507 × GA21 and twenty subcombinations, which have not been authorised previously independently of their origin, for food and feed uses, import and processing under Regulation (EC) No 1829/2003.
DAS-59122-7 × MON-ØØØ21-9
EFSA Journal 2016;14(8):4567, 31 pp. doi:10.2903/j.efsa.2016.4567
SYN-IR6Ø4-5 × DAS-Ø15Ø7-1
SYN-BTØ11-1 × DAS-59122-7 × SYN-IR6Ø4-5 × DAS-Ø15Ø7-1 × MON-ØØØ21-9;
Kommissionens gennemførelsesafgørelse (EU) 2017/1210
Commission Implementing Decision (EU) 2017/1210
om identifikation af bis-(2-ethylhexyl)phthalat (DEHP), dibutylphthalat (DBP), benzylbutylphthalat (BBP) og diisobutylphthalat (DIBP) som særligt problematiske stoffer i henhold til artikel 57, litra f), i Europa-Parlamentets og Rådets forordning (EF) nr. 1907/2006
on the identification of bis(2-ethylhexyl) phthalate (DEHP), dibutyl phthalate (DBP), benzyl butyl phthalate (BBP) and diisobutyl phthalate (DIBP) as substances of very high concern according to Article 57(f) of Regulation (EC) No 1907/2006 of the European Parliament and of the Council
(meddelt under nummer C(2017) 4462)
(notified under document C(2017) 4462)
Bis(2-ethylhexyl)phthalat (DEHP) (EF-nr.
Bis(2-ethylhexyl) phthalate (DEHP), (EC No 204-211-0, CAS No 117-81-7), dibutyl phthalate (DBP) (EC No 201-557-4, CAS No 84-74-2), benzyl butyl phthalate (BBP) (EC No 201-622-7, CAS No 85-68-7) and diisobutyl phthalate (DIBP) (EC No 201-553-2, CAS No 84-69-5) are included in the candidate list referred to in Article 59(1) of Regulation (EC) No 1907/2006 as substances toxic for reproduction (category 1B) according to Article 57(c) of that Regulation.
204-211-0, CAS-nr.
Those substances are also listed in Annex XIV to that Regulation.
117-81-7), dibutylphthalat (DBP) (EF-nr.
In accordance with Article 59(3) of Regulation (EC) No 1907/2006, on 26 August 2014 Denmark submitted to the European Chemicals Agency (hereinafter referred to as ‘the Agency’) four dossiers in accordance with Annex XV to that Regulation (hereinafter referred to as ‘Annex XV dossiers’) for the identification of DEHP, DBP, BBP and DIBP as substances of very high concern under Article 57(f) of that Regulation due to their endocrine disrupting properties for which there is scientific evidence of probable serious effects to human health or the environment which give rise to an equivalent level of concern to those of other substances listed in paragraphs (a) to (e) of Article 57.
201-557-4, CAS-nr.
When the four Annex XV dossiers were considered by the Member State Committee of the Agency (‘MSC’), they were considered in two parts each, one covering the human health aspects and the other covering the environmental aspects of the dossier, respectively.
84-74-2), benzylbutylphthalat (BBP) (EF-nr.
As for the Annex XV dossiers for DBP, BBP and DIBP, the dossier submitter subsequently withdrew the part of its proposal concerning identification of these substances as having endocrine disrupting properties whose effects in relation to the environment give rise to an equivalent level of concern according to Article 57(f) of Regulation (EC) No 1907/2006, in order to further elaborate on the justifications provided in the documentation.
201-622-7, CAS-nr.
On 11 December 2014 the MSC adopted its opinions [2] on the remaining part of the Annex XV dossiers.
85-68-7) og diisobutylphthalat (DIBP) (EF-nr.
The MSC reached a unanimous agreement on the identification of DEHP as having endocrine disrupting properties for which there is scientific evidence of probable serious effects to the environment which give rise to an equivalent level of concern according to Article 57(f) of Regulation (EC) No 1907/2006.
201-553-2, CAS-nr.
Accordingly the Agency amended the DEHP entry in the candidate list on 17 December 2014.
84-69-5) er opført på den liste, der er nævnt i artikel 59, stk. 1, i forordning (EF) nr. 1907/2006, som reproduktionstoksiske stoffer i kategori 1B i henhold til nævnte forordnings artikel 57, litra c).
The MSC unanimously acknowledged that for DEHP, BBP, DBP and DIBP there is scientific evidence on the endocrine activity and on the link between this activity and the adverse effects to human health and further, that the substances can be considered endocrine disruptors for human health as they fulfil the WHO/IPCS definition for an endocrine disruptor and the recommendations from the European Commission's Expert Advisory Group for a substance to be identified as an endocrine disruptor.
Stofferne er også opført i bilag XIV til nævnte forordning.
However, the MSC did not reach unanimous agreement on the identification of the four substances under Article 57(f) of Regulation (EC) No 1907/2006 as giving rise to an equivalent level of concern to those of other substances listed in points (a) to (c) of that Article due to endocrine disrupting properties in relation to human health.
I overensstemmelse med artikel 59, stk. 3, i forordning (EF) nr. 1907/2006, forelagde Danmark den 26. august 2014 Det Europæiske Kemikalieagentur (i det følgende benævnt »agenturet«) fire dossierer i overensstemmelse med bilag XV til nævnte forordning (i det følgende benævnt »bilag XV-dossierer«) om identifikation af DEHP, DBP, BBP og DIBP som særligt problematiske stoffer i henhold til nævnte forordnings artikel 57, litra f), på grund af deres hormonforstyrrende egenskaber, for hvilke der foreligger videnskabelig dokumentation for sandsynlige alvorlige virkninger for menneskers sundhed eller miljøet, der er problematiske i samme grad som virkningerne af de andre stoffer, der er anført i artikel 57, litra a)-e).
According to four members of the MSC the effects for human health pointed out in the Annex XV dossiers were the same effects, caused by the same mode of action, as those already taken into account when the substances were included in the candidate list due to their toxicity for reproduction according to Article 57(c) of that Regulation.
Da de fire bilag XV-dossierer blev behandlet af medlemsstatsudvalget, blev de hver behandlet i to dele, med et dossier om henholdsvis aspektet menneskers sundhed og et om aspektet miljø i dossieret.
On 20 February 2015, pursuant to Article 59(9) of Regulation (EC) No 1907/2006, the MSC referred its opinion to the Commission for a decision on the identification of the four substances as having endocrine disrupting properties for human health giving rise to an equivalent level of concern according to Article 57(f).
Hvad angår bilag XV-dossiererne om DBP, BBP og DIBP trak indsenderen af dossieret senere den del af forslaget tilbage, som vedrører identifikation af disse stoffer som stoffer, der har hormonforstyrrende egenskaber, hvis virkninger for miljøet er problematiske i samme grad i henhold til artikel 57, litra f), i forordning (EF) nr. 1907/2006, for at udbygge begrundelserne i dokumentationen.
The Commission notes the unanimous agreement in MSC that the four substances have endocrine disrupting properties and that the adverse effects caused by this mode of action are the same effects that led to their classification as toxic for reproduction and their identification as substances of very high concern according to Article 57(c) of Regulation (EC) No 1907/2006.
Den 11. december 2014 vedtog medlemsstatsudvalget sine udtalelser [2] om de øvrige dele af bilag XV-dossiererne.
The Commission also notes that the majority of members of the MSC considered that the level of concern of those effects is equivalent to those of substances referred to in Article 57(a) to (e).
Medlemsstatsudvalget nåede enstemmigt til enighed om identifikation af DEHP som havende hormonforstyrrende egenskaber, for hvilke der foreligger videnskabelig dokumentation for sandsynlige alvorlige virkninger for miljøet, som er problematiske i samme grad i henhold til artikel 57, litra f), i forordning (EF) nr. 1907/2006.
The Commission notes that Article 57 does not preclude identifying a substance as being of very high concern several times based on more than one intrinsic property causing the same effect on human health.
I overensstemmelse hermed ændrede agenturet DEHP-indgangen i listen den 17. december 2014.
Therefore DEHP, BBP, DBP and DIBP should be identified under Article 57(f) as substances of very high concern due to their endocrine disrupting properties for which there is scientific evidence of probable serious effects to human health which give rise to an equivalent level of concern to those of other substances listed in paragraph(s) (a) to (e) of that Article.
Medlemsstatsudvalget anerkendte enstemmigt, at der for DEHP, BBP, DBP og DIBP foreligger videnskabelig dokumentation om hormonforstyrrende aktivitet og om sammenhængen mellem denne aktivitet og skadelige virkninger for menneskers sundhed, samt at stofferne kan betragtes som hormonforstyrrende for menneskers sundhed, da de falder ind under WHO/IPCS-definitionen af et hormonforstyrrende stof og henstillingerne fra Europa-Kommissionens ekspertrådgivergruppe om identifikation af et stof som hormonforstyrrende.
This Decision is without prejudice to the outcome of the on-going activities related to the definition of criteria for the identification of endocrine disruptors in accordance with the provisions of Regulation (EC) No 1107/2009 of the European Parliament and of the Council [3], and Regulation (EU) No 528/2012 of the European Parliament and of the Council [4].
Medlemsstatsudvalget nåede imidlertid ikke enstemmigt til enighed om identifikation af de fire stoffer i henhold til artikel 57, litra f), i forordning (EF) nr. 1907/2006 som problematiske i samme grad som de andre stoffer, der er anført i nævnte artikels litra a)-c), på grund af hormonforstyrrende egenskaber vedrørende menneskers sundhed.
The measures provided for in this Decision are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006,
Ifølge fire medlemmer af medlemsstatsudvalget var de i bilag XV-dossiererne anførte virkninger for menneskers sundhed de samme virkninger, forårsaget af samme virkemåde, som dem, der allerede blev taget hensyn til, da stofferne blev optaget på listen på grund af deres reproduktionstoksiske egenskaber i henhold til nævnte forordnings artikel 57, litra c).
HAS ADOPTED THIS DECISION:
I henhold til artikel 59, stk. 9, i forordning (EF) nr. 1907/2006 videresendte medlemsstatsudvalget den 20. februar 2015 sin udtalelse til Kommissionen med henblik på en afgørelse om identifikation af de fire stoffer som stoffer med hormonforstyrrende egenskaber for menneskers sundhed, der er problematiske i samme grad i henhold til artikel 57, litra f).
Sole Article
Kommissionen bemærker medlemsstatsudvalgets enstemmige enighed om, at de fire stoffer har hormonforstyrrende egenskaber, og at de skadelige virkninger, der skyldes denne virkemåde, er de samme virkninger, som førte til deres klassificering som reproduktionstoksiske og deres identifikation som særligt problematiske stoffer i henhold til artikel 57, litra c), i forordning (EF) nr. 1907/2006.
The following substances are identified as substances having endocrine disrupting properties whose effects to human health give rise to an equivalent level of concern according to Article 57(f) of Regulation (EC) No 1907/2006:
Kommissionen bemærker desuden, at et flertal af medlemmerne af medlemsstatsudvalget mener, at virkningerne er problematiske i samme grad som virkningerne af de stoffer, der er omhandlet i artikel 57, litra a)-e).
Bis(2-ethylhexyl) phthalate (DEHP), (EC No 204-211-0, CAS No 117-81-7)
Kommissionen bemærker, at artikel 57 ikke er til hinder for, at et stof identificeres som særligt problematisk flere gange baseret på mere end én iboende egenskab, der har den samme virkning for menneskers sundhed.
Dibutyl phthalate (DBP) (EC No 201-557-4, CAS No 84-74-2)
DEHP, BBP, DBP og DIBP bør derfor identificeres i henhold til artikel 57, litra f), som særligt problematiske på grund af deres hormonforstyrrende egenskaber, for hvilke der foreligger videnskabelig dokumentation for sandsynlige alvorlige virkninger for menneskers sundhed eller miljøet, der er problematiske i samme grad som virkningerne af de andre stoffer, der er anført i nævnte artikels litra a)-e).
Benzyl butyl phthalate (BBP) (EC No 201-622-7, CAS No 85-68-7)
Denne afgørelse berører ikke udfaldet af de igangværende aktiviteter forbundet med fastlæggelsen af kriterier for identifikation af hormonforstyrrende stoffer i overensstemmelse med bestemmelserne i Europa-Parlamentets og Rådets forordning (EF) nr. 1107/2009 [3], og Europa-Parlamentets og Rådets forordning (EU) nr. 528/2012 [4].
Diisobutyl phthalate (DIBP) (EC No 201-553-2, CAS No 84-69-5)
Foranstaltningerne i denne afgørelse er i overensstemmelse med udtalelse fra det udvalg, der er nedsat ved artikel 133 i forordning (EF) nr. 1907/2006 —
The entry of the substances specified in paragraph 1 in the candidate list referred to in Article 59(1) of Regulation (EC) No 1907/2006 shall be amended by adding, under ‘Reason for inclusion’, ‘Equivalent level of concern having probable serious effects to human health’.
VEDTAGET DENNE AFGØRELSE:
This Decision is addressed to the European Chemicals Agency.
Eneste artikel
Done at Brussels, 4 July 2017.
Følgende stoffer identificeres som stoffer med hormonforstyrrende egenskaber, hvis virkninger for menneskers sundhed er problematiske i samme grad i henhold til artikel 57, litra f), i forordning (EF) nr. 1907/2006:
For the Commission
Bis(2-ethylhexyl)phthalat (DEHP) (EF-nr.
Member of the Commission
204-211-0, CAS-nr.
OJ L 396, 30.12.2006, p. 1.
117-81-7)
Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (OJ L 309, 24.11.2009, p. 1).
Dibutylphthalat (DBP) (EF-nr.
Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (OJ L 167, 27.6.2012, p. 1).
Kommissionens gennemførelsesafgørelse (EU) 2017/1211
Commission Implementing Decision (EU) 2017/1211
om tilladelse til markedsføring af produkter, der indeholder, består af eller er fremstillet af genetisk modificeret 281-24-236 × 3006-210-23 × MON 88913-bomuld (DAS-24236-5 × DAS-21Ø23-5 × MON-88913-8), i henhold til Europa-Parlamentets og Rådets forordning (EF) nr. 1829/2003
authorising the placing on the market of products containing, consisting of, or produced from genetically modified cotton 281-24-236 × 3006-210-23 × MON 88913 (DAS-24236-5 × DAS-21Ø23-5 × MON-88913-8) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council
(meddelt under nummer C(2017) 4495)
(notified under document C(2017) 4495)
Den 12. marts 2009 indgav Dow AgroSciences Europe i henhold til artikel 5 og 17 i forordning (EF) nr. 1829/2003 en ansøgning til Nederlandenes kompetente myndighed om tilladelse til markedsføring af fødevarer, fødevareingredienser og foder, der indeholder, består af eller er fremstillet af 281-24-236 × 3006-210-23 × MON 88913-bomuld (i det følgende benævnt »ansøgningen«).
On 12 March 2009, Dow AgroSciences Europe submitted to the competent authority of The Netherlands an application, in accordance with Articles 5 and 17 of Regulation (EC) No 1829/2003, for the placing on the market of foods, food ingredients, and feed containing, consisting of, or produced from 281-24-236 × 3006-210-23 × MON 88913 cotton.
Ansøgningen omfatter også markedsføring af 281-24-236 × 3006-210-23 × MON 88913-bomuld i produkter, der består af eller indeholder denne bomuld, til andre anvendelser end fødevarer og foder, som er tilladt for al anden bomuld, dog ikke til dyrkning.
The application also covers the placing on the market of 281-24-236 × 3006-210-23 × MON 88913 cotton in products consisting of it or containing it for any other uses than food and feed as any other cotton, with the exception of cultivation.
Den Europæiske Fødevaresikkerhedsautoritet (i det følgende benævnt »EFSA«) afgav den 8. april 2016 en positiv udtalelse [3] i henhold til artikel 6 og 18 i forordning (EF) nr. 1829/2003.
On 8 April 2016, the European Food Safety Authority (‘EFSA’) issued a favourable opinion [3] in accordance with Articles 6 and 18 of Regulation (EC) No 1829/2003.
Den konkluderede. at genetisk modificeret 281-24-236 × 3006-210-23 × MON 88913-bomuld er lige så sikker og ernæringsrigtig som sit konventionelle modstykke i forbindelse med de påtænkte anvendelsesformål.
It concluded that genetically modified cotton 281-24-236 × 3006-210-23 × MON 88913 is as safe and as nutritious as its conventional counterpart in the context of its intended uses.
På baggrund af ovenstående bør produkter, der indeholder, består af eller er fremstillet af genetisk modificeret 281-24-236 × 3006-210-23 × MON 88913-bomuld, tillades.
Taking into account those considerations, authorisation should be granted to the products containing, consisting of, or produced from genetically modified cotton 281-24-236 × 3006-210-23 × MON 88913.
Genetisk modificeret 281-24-236 × 3006-210-23 × MON 88913-bomuld bør tildeles en entydig identifikator i overensstemmelse med Kommissionens forordning (EF) nr. 65/2004 [4].
A unique identifier should be assigned to genetically modified cotton 281-24-236 × 3006-210-23 × MON 88913 in accordance with Commission Regulation (EC) No 65/2004 [4].
På grundlag af EFSA's udtalelse synes der ikke at være behov for særlige mærkningsbestemmelser for fødevarer, fødevareingredienser og foder, der indeholder, består af eller er fremstillet af genetisk modificeret 281-24-236 × 3006-210-23 × MON 88913-bomuld, ud over de krav, der er fastsat i artikel 13, stk. 1, og artikel 25, stk. 2, i forordning (EF) nr. 1829/2003.
On the basis of the EFSA opinion, no specific labelling requirements other than those provided for in Article 13(1) and Article 25(2) of Regulation (EC) No 1829/2003 appear to be necessary for foods, food ingredients and feed containing, consisting of, or produced from cotton 281-24-236 × 3006-210-23 × MON 88913.